Proteomic profiling of patient‐derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development
暂无分享,去创建一个
K. Hoadley | S. Keir | D. Bigner | E. Lipp | Roger R. McLendon | F. Ali-Osman | M. Cooter | J. Sampson | T. Yen | S. Kwatra | Kristine E. Brown | G. Chagoya | M. Kwatra | A. Rasheed | R. McLendon | Gustavo Chagoya